Projects funded by the NCN
Simultaneous stimulation of muscarinic M4 receptor and selected receptors involved in the regulation of glutamate release (mGlu2, mGlu4 or GABAB) as the new target in the search for effective antipsychotic drugs.The role of special drug combinations in the context of positive, negative and cognitive symptoms of schizophrenia.
2015/17/B/NZ7/02984
Keywords:
schizophrenia mGlu2 mGlu4 GABAB muscarinic M4
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: OPUS 9 - announced on 2015-03-16
Amount awarded: 629 400 PLN
Project start date (Y-m-d): 2016-02-15
Project end date (Y-m-d): 2020-02-14
Project duration:: 48 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.